US Patent Issued to The Johns Hopkins University, Institute of Organic Chemistry & Biochemistry as CR V.V.I. on Aug. 4 for "Bile acid-GCPII inhibitor conjugates to treat inflammatory diseases, including inflammatory bowel disease (IBD)" (Czech, American Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,306, issued on Aug. 4, was assigned to The Johns Hopkins University (Baltimore) and Institute of Organic Chemistry & Biochemistry as CR V.V.I. (Prague).

"Bile acid-GCPII inhibitor conjugates to treat inflammatory diseases, including inflammatory bowel disease (IBD)" was invented by Barbara Slusher (Baltimore), Diane E. Peters (Baltimore), Rana Rais (Baltimore), Pavel Majer (Prague), Lukas Tenora (Prague) and Ivan Snajdr (Prague).

According to the abstract* released by the U.S. Patent & Trademark Office: "GCPII inhibitors comprising 2-(phosphonomethyl) pentanedioic acid (2-PMPA) conjugated to a bile acid and their use for treating a disease or condition associated with elevated lev...